what happened to tirzepatide Did the FDA Ban Compounded Semaglutide and Tirzepatide? when do tirzepatide side effects

Science 2023;381:eabl7398.PubMed 63

Kelner MJ, Montoya MA

Key Events in Mounjaros FDA Approval and Label Updates May 2025 Warning of acute pancreatitis risk and acute kidney injury due to dehydration added to Mounjaros label

The end of the official shortage status for semaglutide came as telehealth company Hims & Hers which has been pushing sales of compounded semaglutide hard and lambasting the pharma industry for restricting access to GLP-1 drugs bought a peptide facility to raise its manufacturing capacity, sparking a sharp drop in its share price

Taken together, the data suggest that FATP2 deletion did not directly influence GLP-1 synthesis or secretion by enteroendocrine cells

It also calls for regular follow-up visits covering glucose checks, medication reconciliation, and symptom review as weight and metabolism shift over time